Summit Therapeutics plc Gains 48.18%
Mon, Aug 22, 2022 at 06:55 PM
Summit Therapeutics plc (SMMT:NASDAQ) soared at $1.63, representing a gain of 48.2%. On Mon, Aug 22, 2022, SMMT:NASDAQ hit a New 2-Week High of $1.63. The stock appeared on our News Catalysts scanner on Fri, Aug 19, 2022 at 02:15 PM in the 'MISCELLANEOUS' category. From Mon, Aug 08, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About Summit Therapeutics plc (SMMT:NASDAQ)
Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.
Top 10 Gainers:
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 72.8%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 66.01%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- Summit Therapeutics plc (SMMT:NASDAQ), 48.18%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 47.83%
- Wag! Group Co. (PET:NASDAQ), 47.01%
- Bon Natural Life Limited (BON:NASDAQ), 36.45%
- Signify Health Inc. Class A (SGFY:NYSE), 32.08%
- Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ), 30.68%
- Blue Apron Holdings, Inc. (APRN:NYSE), 26.34%